DK168624B1 - Process for Preparation of 5-Chloro-2-Methoxynicotinic Acid by Chlorination of 2-Methoxynicotinic Acid - Google Patents

Process for Preparation of 5-Chloro-2-Methoxynicotinic Acid by Chlorination of 2-Methoxynicotinic Acid Download PDF

Info

Publication number
DK168624B1
DK168624B1 DK225888A DK225888A DK168624B1 DK 168624 B1 DK168624 B1 DK 168624B1 DK 225888 A DK225888 A DK 225888A DK 225888 A DK225888 A DK 225888A DK 168624 B1 DK168624 B1 DK 168624B1
Authority
DK
Denmark
Prior art keywords
methoxynicotinic acid
chloro
acid
methoxynicotinic
chlorination
Prior art date
Application number
DK225888A
Other languages
Danish (da)
Other versions
DK225888D0 (en
DK225888A (en
Inventor
Carl Joseph Goddard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK225888D0 publication Critical patent/DK225888D0/en
Publication of DK225888A publication Critical patent/DK225888A/en
Application granted granted Critical
Publication of DK168624B1 publication Critical patent/DK168624B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B39/00Halogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

A novel process for chlorinating 2-methoxynicotinic acid at the 5-position of the molecule is disclosed. The process involves the use of an alkali metal hypochlorite as the chlorinating agent in a homogeneous aqueous solvent system. The compound so produced, 5-chloro-2-methoxynicotinic acid, is known to be useful as an intermediate leading to various oral hypoglycemic agents of the benzenesulfonylurea class.

Description

i DK 168624 B1in DK 168624 B1

Denne opfindelse angår en særlig fremgangsmåde til fremstilling af 5-chlor-2-methoxynicotinsyre ved chlorering af 2-methoxynicotinsyre i molekylets 5-stilling. Den fremstillede 5-chlor-2-methoxynicotinsyre er en kendt 5 forbindelse, som vides at være af værdi som mellemprodukt ved fremstillingen af visse benzensulfonylurinstofforbin-delser, som er orale hypoglycæmiske midler.This invention relates to a particular process for preparing 5-chloro-2-methoxynicotinic acid by chlorinating 2-methoxynicotinic acid at the 5-position of the molecule. The 5-chloro-2-methoxynicotinic acid produced is a known compound which is known to be of value as an intermediate in the preparation of certain benzenesulfonylurea compounds which are oral hypoglycemic agents.

Tidligere er 5-chlor-2-methoxynicotinsyre blevet frem-10 stillet ved chlorering af 2-methoxynicotinsyre med chlor i overensstemmelse med den fremgangsmåde, der er beskrevet af D.E. Kuhla et al. i US patentskrift nr. 3 879 403. Imidlertid involverer denne fremgangsmåde anvendelsen af chlorgas med de dermed forbundne risici og anvendelsen af 15 et vandigt opløsningsmiddelsystem, som fører til heterogene reaktionsbetingelser med de deraf følgende ulemper.In the past, 5-chloro-2-methoxynicotinic acid has been prepared by chlorination of 2-methoxynicotinic acid with chlorine in accordance with the procedure described by D.E. Kuhla et al. in U.S. Patent No. 3,879,403. However, this process involves the use of chlorine gas with the associated risks and the use of an aqueous solvent system which leads to heterogeneous reaction conditions with the resulting disadvantages.

I eftersøgningen af forbedrede fremgangsmåder til chlorering indenfor dette bestemte område vides kun lidt om anvendelsen af andre chloreringsmidler til indføring af 20 chlor på pyridinringen, selv om disse midler er blevet anvendt med varierende held indenfor den ikke-heterocy-cliske kemis område. For eksempel er alkalimetalhypochlo-ritopløsninger tidligere blevet anvendt til at chlorere nitroparaffiner indenfor et vist afgrænset pH-område 25 (f.eks. pH 10-14) ifølge den fremgangsmåde, der er beskrevet af J.B. Tindall i US patentskrift nr. 2 365 981, medens lignende opløsninger også er blevet anvendt ved chloreringen af p-hydroxybiphenyl til dannelse af 3-chlor-4-hydroxybiphenyl ifølge den fremgangsmåde, der er 30 beskrevet af E.F. Grether i US patentskrift nr.In the search for improved methods of chlorination in this particular area, little is known about the use of other chlorinating agents for introducing 20 chlorine into the pyridine ring, although these agents have been used with varying success in the field of non-heterocyclic chemistry. For example, alkali metal hypochlorite solutions have previously been used to chlorine nitroparaffins within a certain defined pH range (e.g., pH 10-14) according to the method described by J.B. Tindall in US Patent No. 2 365 981, while similar solutions have also been used in the chlorination of p-hydroxybiphenyl to form 3-chloro-4-hydroxybiphenyl according to the process described by E.F. Grether in U.S. Pat.

1 832 484.1 832 484.

I overensstemmelse med den foreliggende opfindelse har det nu vist sig muligt selektivt at chlorere 2-methoxy-35 nicotinsyre i molekylets 5-stilling og således opnå 5-chlor-2-methoxynicotinsyre i ren form og i højt udbytte ved anvendelse af et alkalimetalhypochlorit som chlore- DK 168624 B1 2 ringsmiddel i et vandigt opløsningsmiddel sy stem.In accordance with the present invention, it has now been found possible to selectively chlorine 2-methoxy-nicotinic acid at the 5-position of the molecule and thus obtain 5-chloro-2-methoxynicotinic acid in pure form and in high yield using an alkali metal hypochlorite as chlorine - DK 168624 B1 2 solvent in an aqueous solvent sy stem.

Fremgangsmåden ifølge opfindelsen er ejendommelig ved, at 2-methoxynicotinsyre underkastes den chlorerende virkning 5 af et alkalimetalhypochlorit i et homogent vandigt opløsningsmiddelsystem ved en temperatur i området fra omkring 10 til omkring 30 °C, indtil chloreringsreaktionen er i det væsentlige fuldført.The process of the invention is characterized in that 2-methoxynicotinic acid is subjected to the chlorinating action of an alkali metal hypochlorite in a homogeneous aqueous solvent system at a temperature in the range of about 10 to about 30 ° C until the chlorination reaction is substantially complete.

10 På denne måde omdannes 2-methoxynicotinsyre let og direkte til 5-chlor-2-methoxynicotinsyre uden de tidligere omtalte ulemper forbundet med anvendelsen af gasformigt chlor.In this way, 2-methoxynicotinic acid is easily and directly converted to 5-chloro-2-methoxynicotinic acid without the aforementioned disadvantages associated with the use of gaseous chlorine.

15 Ved fremgangsmåden ifølge opfindelsen er forholdet mellem 2-methoxynicotinsyre-udgangsmaterialet og alkalimetalhypochlorit-reagenset, der anvendes som chloreringsmiddel, sædvanligvis i området fra omkring 1,0:1,0 til omkring 1,0:6,0, idet det foretrukne område er fra omkring 20 1,0:1,2 til omkring 1,0:2,0, for at frembringe den ønskede chlorering i molekylets 5-stilling. Foretrukne reaktionsbetingelser består i gennemførelse af reaktionen ved omkring stuetemperatur i et tidsrum på mindst ca. 16 timer. Selv om ethvert alkalimetalhypochlorit, såsom li-25 thium-, natrium- eller kaliumhypochlorit, kan anvendes ved fremgangsmåden, er det foretrukne reagens natrium-hypochlorit. Som følge heraf har det vist sig mest hensigtsmæssigt at udføre reaktionen i en fortyndet vandig natriumhypochloritopløsning, f.eks. en 5,25 % vandig op-30 løsning af natriumhypochlorit, som kan skaffes kommer cielt under handelsnavnet "Clorox". Efter fuldførelse af reaktionen udvindes det ønskede produkt, 5-chlor-2-methoxynicotinsyre, let fra reaktionsblandingen ved simpel syrning og filtrering eller ved syrning og ekstraktion 35 med et egnet opløsningsmiddel, såsom chloroform, om nødvendigt efterfulgt af yderligere rensning via udrivning med et passende opløsningsmiddel, der normalt anvendes DK 168624 B1 3 til disse formål (f.eks. hexan).In the process of the invention, the ratio of the 2-methoxynicotinic starting material to the alkali metal hypochlorite reagent used as the chlorinating agent is usually in the range of about 1.0: 1.0 to about 1.0: 6.0, the preferred range being from about 20 1.0: 1.2 to about 1.0: 2.0 to produce the desired chlorination at the 5-position of the molecule. Preferred reaction conditions consist in carrying out the reaction at about room temperature for a period of at least about 30 minutes. 16 hours. Although any alkali metal hypochlorite, such as lithium, sodium or potassium hypochlorite, can be used in the process, the preferred reagent is sodium hypochlorite. As a result, it has been found most convenient to carry out the reaction in a dilute aqueous sodium hypochlorite solution, e.g. a 5.25% aqueous solution of sodium hypochlorite which can be obtained comes cially under the trade name "Clorox". Upon completion of the reaction, the desired product, 5-chloro-2-methoxynicotinic acid, is readily recovered from the reaction mixture by simple acidification and filtration or by acidification and extraction with a suitable solvent such as chloroform, if necessary, followed by further purification by tearing with an appropriate solvent usually used for these purposes (eg hexane).

Som tidligere anført er produktet af fremgangsmåden ifølge opfindelsen, nemlig 5-chlor-2-methoxynicotinsyre, en 5 kendt forbindelse, der tjener som et værdifuldt mellemprodukt, som i sidste ende fører til visse benzensulfo-nylurinstofforbindelser, der er orale hypoglycæmiske midler, som er beskrevet og patenteret af D.E. Kuhla et al. i US patentskrift nr. 3 879 403. Mere specifikt omdannes 10 5-chlor-2-methoxynicotinsyre først til 5-chlor-2-methoxy-nicotinoylchlorid, som derpå omdannes til 4-[2-(5-chlor- 2-methoxynicotinamido)ethyl]benzensulfonamid, hvilket til sidst giver l-cyclohexyl-3-{4-[2-(5-chlor-2-methoxynico-tinamido)ethyl]benzensulfonyl}-urinstof eller l-(bicyc-15 lo[2.2.1]hept-5-en-2-yl-endo-methyl)-3-{4-[2-(5-chlor-2- methoxynicotinamido)ethyl]benzensulfonyl}urinstof eller 1-(4-chlorcyclohexyl)-3-{4-[2-(5-chlor-2-methoxynicotin-amido)ethyl]benzensulfonyl}urinstof ved den kendte fler-trins-fremgangsmåde, som tidligere er beskrevet af D.E.As previously stated, the product of the process of the invention, namely 5-chloro-2-methoxynicotinic acid, is a known compound which serves as a valuable intermediate which ultimately leads to certain benzenesulfonylurea compounds which are oral hypoglycemic agents which are described and patented by DE Kuhla et al. U.S. Patent No. 3,879,403. More specifically, 5-chloro-2-methoxynicotinic acid is first converted to 5-chloro-2-methoxy-nicotinoyl chloride, which is then converted to 4- [2- (5-chloro-2-methoxynicotinamido) ethyl] benzenesulfonamide, eventually giving 1-cyclohexyl-3- {4- [2- (5-chloro-2-methoxynico-tinamido) ethyl] benzenesulfonyl} urea or 1- (bicyclo [2.2.1]) hept-5-en-2-yl-endo-methyl) -3- {4- [2- (5-chloro-2-methoxynicotinamido) ethyl] benzenesulfonyl} urea or 1- (4-chlorocyclohexyl) -3- {4 - [2- (5-chloro-2-methoxynicotinamido) ethyl] benzenesulfonyl} urea by the known multi-step method previously described by DE

20 Kuhla et al. i det førnævnte US patentskrift.Kuhla et al. in the aforementioned US patent.

Således tilvejebringer den hidtil ukendte fremgangsmåde ifølge opfindelsen nu det værdifulde mellemprodukt, 5-chlor-2-methoxynicotinsyre, i ren form og i højt udbytte 25 ved en ejendommelig selektiv 1-trins-chloreringsmetode, som repræsenterer en større forbedring i forhold til den kendte teknik i betragtning af syntesens lethed og stærkt reducerede omkostninger. Mere specifikt undgår den anvendelsen af chlorgas og de dermed forbundne risici og gør 30 det muligt at gennemføre reaktionen under normale homogene reaktionsbetingelser, hvorved man undgår uhåndterlige og besværlige suspensioner.Thus, the novel process of the invention now provides the valuable intermediate, 5-chloro-2-methoxynicotinic acid, in pure form and in high yield 25 by a peculiar selective 1-step chlorination method which represents a greater improvement over the prior art. given the ease of the synthesis and greatly reduced costs. More specifically, it avoids the use of chlorine gas and the associated risks and allows the reaction to be carried out under normal homogeneous reaction conditions, avoiding unmanageable and cumbersome suspensions.

Præparation A 35Preparation A 35

En omrørt opslæmning bestående af 35 g (0,22 mol) 2-chlornicotinsyre (kan skaffes fra Lonza Inc., Fair Lawn, 4 DK 168624 BlA stirred slurry consisting of 35 g (0.22 mol) of 2-chloronicotinic acid (available from Lonza Inc., Fair Lawn, 4 DK 168624 B1

New Jersey, USA) i 400 ml methanol blev behandlet med 25,4 g (0,47 mol) natriummethyl at, som tilsattes portionsvist. Omrøringen fortsattes derpå, indtil der blev opnået en klar opløsning. Ved dette punkt blev den fly-5 dende reaktionsblanding overført til en stålautoklav og opvarmet til 125 °C i omkring 16 timer (dvs. natten over). Efter fuldførelse af dette trin blev reaktionsblandingen afkølet til stuetemperatur (ca. 20 °C), filtreret, og filterkagen blev vasket med methanol. Kombina-10 tionen af organisk filtrat og methanolvaskeopløsninger blev derpå koncentreret i vakuum, hvilket gav et hvidt fast materiale, som derefter blev opløst i vand. Den vandige opløsning blev derpå indstillet til pH 3,0 ved hjælp af 6 N saltsyre og øjeblikkeligt filtreret for at fjerne 15 (dvs. udvinde) det udfældede faste produkt, som derefter blev lufttørret til konstant vægt i omkring 16 timer (dvs. natten over). På denne måde blev der til sidst opnået 21,8 g (64 %) ren 2-methoxynicotinsyre, smp. 147-148 eC (literatur-smp. 144-146 °C, ifølge D.E. Kuhla et al. i 20 US patentskrift nr. 3 879 403). Det rene produkt blev yderligere karakteriseret ved hjælp af magnetisk-kernere-sonans-data.New Jersey, USA) in 400 ml of methanol was treated with 25.4 g (0.47 mole) of sodium methyl at which was added portionwise. Stirring was then continued until a clear solution was obtained. At this point, the liquid reaction mixture was transferred to a steel autoclave and heated to 125 ° C for about 16 hours (i.e. overnight). After completing this step, the reaction mixture was cooled to room temperature (about 20 ° C), filtered and the filter cake washed with methanol. The combination of organic filtrate and methanol washing solutions was then concentrated in vacuo to give a white solid which was then dissolved in water. The aqueous solution was then adjusted to pH 3.0 with 6N hydrochloric acid and immediately filtered to remove 15 (i.e., recover) the precipitated solid which was then air dried to constant weight for about 16 hours (i.e. overnight). ). In this way, 21.8 g (64%) of pure 2-methoxynicotinic acid was finally obtained, m.p. 147-148 ° C (literature mp 144-146 ° C, according to D.E. Kuhla et al. In U.S. Patent No. 3,879,403). The pure product was further characterized by magnetic-nuclear-sonance data.

Eksempel 1 25Example 1 25

En prøve på 306 mg (0,002 mol) af 2-methoxynicotinsyre (produktet fra præparation A) sattes i en portion til 20 ml godt omrørt vandig 5,25 % natriumhypochloritopløsning ("Clorox"). Den resulterende blanding (nu en opløsning) 30 blev derpå omrørt ved stuetemperatur (ca. 20 °C) i omkring 18 timer (dvs. natten over). Efter fuldførelse af dette trin blev reaktionsblandingen gjort sur med 10 ml 1 N saltsyre, og det resulterende bundfald blev derefter ekstraheret med chloroform. De organiske ekstrakter blev 35 kombineret, tørret over vandfrit magnesiumsulfat og filtreret, og filtratet blev derefter koncentreret i vakuum, hvilket gav 195 mg (52 %) ren 5-chlor-2-methoxynicotin- DK 168624 B1 5 syre, smp. 139-141 °C (literatur-smp. 149-150 °C, ifølge D.E. Kuhla et al. i US patentskrift nr. 3 879 403). Det rene produkt blev yderligere karakteriseret ved hjælp af magnetisk-kerneresonans-data og massespektroskopi.A sample of 306 mg (0.002 mol) of 2-methoxynicotinic acid (the product of Preparation A) was added in a portion to 20 ml of well stirred aqueous 5.25% sodium hypochlorite solution ("Clorox"). The resulting mixture (now a solution) was then stirred at room temperature (about 20 ° C) for about 18 hours (i.e. overnight). After completion of this step, the reaction mixture was acidified with 10 ml of 1 N hydrochloric acid and the resulting precipitate was then extracted with chloroform. The organic extracts were combined, dried over anhydrous magnesium sulfate and filtered and the filtrate was then concentrated in vacuo to give 195 mg (52%) of pure 5-chloro-2-methoxynicotinic acid, m.p. 139-141 ° C (literature mp 149-150 ° C, according to D.E. Kuhla et al. In U.S. Patent No. 3,879,403). The pure product was further characterized by magnetic-nuclear resonance data and mass spectroscopy.

55

Eksempel 2Example 2

En prøve på 217 g (1,42 mol) af 2-methoxynicotinsyre (produktet fra præparation A) sattes portionsvis til 2,5 10 liter godt omrørt vandig 5,25 % natriumhypochloritopløs-ning ("Clorox") ved 10 °C, idet der opretholdtes tilstrækkelig køling under hele tilsætningens forløb til at holde reaktionsblandingens temperatur under 28 °C. Efter fuldførelse af dette trin blev reaktionsblandingen omrørt 15 ved stuetemperatur (ca. 20 °C) i omkring 16 timer (dvs. natten over) og blev derpå gjort sur til pH 2,0 med koncentreret saltsyre. Det udfældede faste produkt blev opsamlet ved hjælp af sugefiltrering og derefter udrevet med to 500 ml-portioner hexan efterfulgt af tørring under 20 høj vakuum, hvilket til sidst gav 201 g (75 %) ren 5- chlor-2-methoxynicotinsyre. Dette produkt var identisk i enhver henseende med produktet fra eksempel 1, som især bekræftet ved magnetisk-kerneresonans-data.A sample of 217 g (1.42 mol) of 2-methoxynicotinic acid (the product of Preparation A) was added portionwise to 2.5 10 liters of well stirred aqueous 5.25% sodium hypochlorite solution ("Clorox") at 10 ° C, sufficient cooling was maintained throughout the course of the addition to keep the reaction mixture temperature below 28 ° C. After completing this step, the reaction mixture was stirred at room temperature (about 20 ° C) for about 16 hours (i.e., overnight) and then acidified to pH 2.0 with concentrated hydrochloric acid. The precipitated solid product was collected by suction filtration and then triturated with two 500 ml portions of hexane followed by drying under high vacuum to give 201 g (75%) of pure 5-chloro-2-methoxynicotinic acid. This product was identical in every respect to the product of Example 1, as confirmed especially by magnetic-nuclear resonance data.

25 Eksempel 3 I en 22 liters trehalset, rundbundet reaktionskolbe udstyret med termometer, mekanisk omrører og udluftning anbragtes 12 liter vandig 5,25 % natriumhypochloritopløs-30 ning ("Clorox”) ved 10 °C. Omrøringen blev startet, og der sattes portionsvis 868 g (5,66 mol) 2-methoxynicotinsyre til den omrørte opløsning i løbet af 75 minutter, idet der opretholdtes tilstrækkelig køling under hele tilsætningens forløb til at holde reaktionsblandingens 35 temperatur under 30 °C. Efter fuldførelse af dette trin blev den resulterende hvide opslæmning ved 21 °C behandlet med yderligere 4 liter frisk vandig 5,25 % natriumhy- 6 DK 168624 B1 pochloritopløsning ("Clorox") for at bringe reaktionsblandingens pH-værdi til omkring pH 7,0. Den sidstnævnte blanding blev derefter omrørt ved stuetemperatur i omkring 18 timer. Den resulterende lysebrune opslæmning 5 blev derpå behandlet med 3,5 liter chloroform, og pH-vær-dien blev indstillet til ca. 1,5 ved tilsætning af koncentreret saltsyre, efterfulgt af yderligere fortynding med 5,2 liter chloroform. Det fraskilte chloroformlag blev derpå filtreret og opbevaret, medens det vandige lag 10 blev ekstraheret med 3,5 liter frisk chloroform. De kombinerede organiske lag blev derefter vasket en gang med 4 liter 10 % vandig saltsyre og tørret over vandfrit magnesiumsulfat. Efter fjernelse af tørringsmidlet ved filtrering og af opløsningsmidlet ved inddampning under reduce-15 ret tryk blev der opnået et gullighvidt fast stof, som derefter blev udrevet med 3 liter hexan og filtreret. Det resulterende næsten hvide faste stof blev derpå vasket med en liter frisk hexan på filtertragten og lufttørret til konstant vægt i omkring 16 timer, hvilket til sidst 20 gav 782,4 g (73 %) ren 5-chlor-2-methoxynicotinsyre, smp. 137-138 °C. Dette produkt var identisk i enhver henseende med produktet fra eksempel 1, som især bekræftet ved mag-netisk-kerneresonans-data.Example 3 A 12 liter aqueous 5.25% sodium hypochlorite solution ("Clorox") solution was placed at 10 ° C. in a 22 liter three-necked, round bottom flask equipped with a thermometer, mechanical stirrer, and vented. g (5.66 mole) of 2-methoxynicotinic acid to the stirred solution over 75 minutes, maintaining sufficient cooling throughout the course of the addition to keep the reaction mixture temperature below 30 ° C. After completion of this step, the resulting white slurry became at 21 ° C treated with an additional 4 liters of fresh aqueous 5.25% sodium hydrochloric acid solution ("Clorox") to bring the pH of the reaction mixture to about pH 7.0. The latter mixture was then stirred at room temperature for 1 hour. The resulting light brown slurry 5 was then treated with 3.5 liters of chloroform and the pH was adjusted to about 1.5 by the addition of conc. enteric hydrochloric acid, followed by further dilution with 5.2 liters of chloroform. The separated chloroform layer was then filtered and stored, while the aqueous layer 10 was extracted with 3.5 liters of fresh chloroform. The combined organic layers were then washed once with 4 liters of 10% aqueous hydrochloric acid and dried over anhydrous magnesium sulfate. After removing the desiccant by filtration and the solvent by evaporation under reduced pressure, a yellowish-white solid was obtained, which was then triturated with 3 liters of hexane and filtered. The resulting almost white solid was then washed with a liter of fresh hexane on the filter funnel and air dried to constant weight for about 16 hours, finally giving 782.4 g (73%) of pure 5-chloro-2-methoxynicotinic acid, m.p. 137-138 ° C. This product was identical in every respect to the product of Example 1, as confirmed in particular by magnetic nuclear resonance data.

25 30 3525 30 35

Claims (6)

1. Fremgangsmåde til fremstilling af 5 -chlor- 2-methoxy-5 nicotinsyre ved chlorering af 2-methoxynicotinsyre, kendetegnet ved, at 2-methoxynicotinsyre udsættes for den chlorerende virkning af et alkalimetalhypo-chlorit i et homogent vandigt opløsningsmiddelsystem ved en temperatur i området fra omkring 10 til omkring 30 eC, 10 indtil chloreringsreaktionen er i det væsentlige fuldført.Process for the preparation of 5-chloro-2-methoxy-nicotinic acid by chlorination of 2-methoxynicotinic acid, characterized in that 2-methoxynicotinic acid is exposed to the chlorinating effect of an alkali metal hypochlorite in a homogeneous aqueous solvent system at a temperature in the region from about 10 to about 30 eC, 10 until the chlorination reaction is substantially complete. 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at det som reagens anvendte alkalimetalhypochlorit 15 er natriumhypochlorit.Process according to claim 1, characterized in that the alkali metal hypochlorite 15 used as a reagent is sodium hypochlorite. 3. Fremgangsmåde ifølge krav 2, kendetegnet ved, at det molære forhold mellem 2-methoxynicotinsyre-udgangsmaterialet og natriumhypochlorit-reagenset er i 20 området fra omkring 1,0:1,0 til omkring 1,0:6,0.Process according to claim 2, characterized in that the molar ratio of the 2-methoxynicotinic acid starting material to the sodium hypochlorite reagent is in the range from about 1.0: 1.0 to about 1.0: 6.0. 4. Fremgangsmåde ifølge krav 3, kendetegnet ved, at det molære forhold er i området fra omkring 1,0:1,2 til omkring 1,0:2,0. 25Process according to claim 3, characterized in that the molar ratio is in the range from about 1.0: 1.2 to about 1.0: 2.0. 25 5. Fremgangsmåde ifølge ethvert af de forudgående krav, kendetegnet ved, at reaktionen gennemføres ved stuetemperatur i mindst ca. 16 timer.Process according to any one of the preceding claims, characterized in that the reaction is carried out at room temperature for at least approx. 16 hours. 6. Fremgangsmåde ifølge ethvert af de forudgående krav, kendetegnet ved, at den fremstillede 5-chlor-2-methoxynicotinsyre udvindes fra reaktionsblandingen. 35Process according to any one of the preceding claims, characterized in that the 5-chloro-2-methoxynicotinic acid produced is recovered from the reaction mixture. 35
DK225888A 1987-04-27 1988-04-26 Process for Preparation of 5-Chloro-2-Methoxynicotinic Acid by Chlorination of 2-Methoxynicotinic Acid DK168624B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/043,056 US4716231A (en) 1987-04-27 1987-04-27 Chlorination of 2-methoxynicotinic acid
US4305687 1987-04-27

Publications (3)

Publication Number Publication Date
DK225888D0 DK225888D0 (en) 1988-04-26
DK225888A DK225888A (en) 1988-10-28
DK168624B1 true DK168624B1 (en) 1994-05-09

Family

ID=21925225

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225888A DK168624B1 (en) 1987-04-27 1988-04-26 Process for Preparation of 5-Chloro-2-Methoxynicotinic Acid by Chlorination of 2-Methoxynicotinic Acid

Country Status (18)

Country Link
US (1) US4716231A (en)
EP (1) EP0289180B1 (en)
JP (1) JPH0625117B2 (en)
KR (1) KR900006208B1 (en)
AT (1) ATE82965T1 (en)
AU (1) AU581829B2 (en)
CA (1) CA1297114C (en)
DE (1) DE3876277T2 (en)
DK (1) DK168624B1 (en)
ES (1) ES2035917T3 (en)
FI (1) FI89044C (en)
GR (1) GR3006528T3 (en)
HU (1) HU202206B (en)
IE (1) IE61278B1 (en)
IL (1) IL86115A (en)
NZ (1) NZ224376A (en)
PT (1) PT87334B (en)
ZA (1) ZA882937B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133447A (en) * 1998-02-27 2000-10-17 Novartis Crop Protection, Inc. Process for the preparation of substituted pyridines
JP5148836B2 (en) * 2005-04-21 2013-02-20 石原産業株式会社 Process for producing nicotinic acid derivative or salt thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1832484A (en) * 1928-10-11 1931-11-17 Dow Chemical Co Derivatives of para-hydroxy-diphenyl
US2365981A (en) * 1941-12-20 1944-12-26 Commercial Solvents Corp Production of chlorinated nitro hydrocarbons
US3879403A (en) * 1973-05-04 1975-04-22 Pfizer Benzenesulfonylurea derivatives

Also Published As

Publication number Publication date
EP0289180A3 (en) 1989-12-13
KR880012505A (en) 1988-11-28
FI881949A0 (en) 1988-04-26
JPS63280065A (en) 1988-11-17
AU581829B2 (en) 1989-03-02
FI881949A (en) 1988-10-28
IE881246L (en) 1988-10-27
GR3006528T3 (en) 1993-06-30
PT87334B (en) 1992-08-31
HU202206B (en) 1991-02-28
NZ224376A (en) 1989-12-21
DE3876277T2 (en) 1993-04-01
JPH0625117B2 (en) 1994-04-06
IL86115A (en) 1992-02-16
IE61278B1 (en) 1994-10-19
US4716231A (en) 1987-12-29
FI89044B (en) 1993-04-30
IL86115A0 (en) 1988-11-15
EP0289180B1 (en) 1992-12-02
ATE82965T1 (en) 1992-12-15
AU1514488A (en) 1988-10-27
CA1297114C (en) 1992-03-10
DK225888D0 (en) 1988-04-26
KR900006208B1 (en) 1990-08-25
DE3876277D1 (en) 1993-01-14
ES2035917T3 (en) 1993-05-01
EP0289180A2 (en) 1988-11-02
ZA882937B (en) 1989-12-27
PT87334A (en) 1988-05-01
HUT49331A (en) 1989-09-28
FI89044C (en) 1993-08-10
DK225888A (en) 1988-10-28

Similar Documents

Publication Publication Date Title
HU182707B (en) Process for isolating the salts of p-hydroxy-mandolic acid
US6008381A (en) Process for preparing 3-isochromanone
DK168624B1 (en) Process for Preparation of 5-Chloro-2-Methoxynicotinic Acid by Chlorination of 2-Methoxynicotinic Acid
US3978085A (en) Process for benz[f]-2,5-oxazocines
JPH059177A (en) New nitrogen-containing heterocyclic compound
NO147838B (en) INTERMEDIATE FOR USE IN PREPARATION OF THE HYPOTENSIVE AGENT 2- (4- (2-FUROYL) PIPERAZIN-1-YL) -4-AMINO-6,7-DIMETOXYKINAZOLINE
NO170542B (en) PROCEDURE FOR MANUFACTURING A BASIC THIOETHER AND SALT THEREOF
EP0010262B1 (en) Process for preparing 3-amino-5-t-butylisoxazole
US4082766A (en) Process for preparing n-chlorophthalimide
US5290943A (en) Method of producing 2-acyl amino 5-halogenopyridine compounds
JP3259196B2 (en) Method for producing 2-hydrazino-4,6-dimethoxypyrimidine
DK145741B (en) METHOD FOR PREPARING 6-CHLOR-ALFA-METHYL-CARBAZOL-2-ACETIC ACID
JPH03135956A (en) Method for preparation of 3-trichloromethyl pyridine
BG61912B1 (en) New method for the preparation of 3,4-dihydroxy-5-nitrobenzaldenyde
US4235813A (en) Aromatic sulfonamide sulfonyl chloride compounds
RU2161605C2 (en) Substituted quinolines as semiproducts for herbicide production and method of their synthesis
JPH0278655A (en) Production of p-toluenesulfonylacetic acid
JPH0585985A (en) Production of optically active atrolactinic acid and intermediate for production
DK160819B (en) METHOD OF PREPARING 3,5-DICHLOR-2-PYRIDON
JPS58222070A (en) Preparation of 4-hydroxy-5-halogeno-6-alkylpyrimidine hydrogen halide
JPS6225145B2 (en)
JPH1045779A (en) Chlorination of phenylphosphonic acid
JPH0681746B2 (en) 1-Hydroxypyrazol-4-carboxylic acid and process for producing the same
NO179793B (en) Process for the synthesis of trisodium phosphonoformate hexahydrate
JPH01143875A (en) Industrial production of furobenzoisoxazole derivative

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed